Add Tribune As Your Trusted Source
TrendingVideosIndia
Opinions ▾
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC ▾
UPSC | Exam ScheduleExam Mentor
State ▾
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City ▾
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World ▾
World | ChinaUnited StatesPakistan
Diaspora
Features ▾
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business ▾
Business | My MoneyAutoZone
News Columns ▾
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill ViewBenchmark
Don't Miss
Advertisement
Home / Nation / Bharat Biotech Revises Covaxin Price To State Govts To Rs 400 Per Dose 245923

Bharat Biotech cuts vaccine price for states to Rs 400 per dose

Tribune Web Desk
Updated At : 11:40 PM Apr 29, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, April 29

Advertisement

Bharat Biotech on Thursday announced a cut in price of its COVID-19 vaccine ‘Covaxin’ it plans to sell to the states to Rs 400 per dose from the earlier Rs 600.

Advertisement

This follows a widespread criticism of its pricing policy as it sold Covaxin to the Central government at Rs 150 per dose.

Also read:

Serum Institute brings Covishield procurement price for states down to Rs 300

Advertisement

“Recognising the enormous challenges in the public healthcare system, we have made Covaxin available to state governments at a price of 400/dose”, Bharat Biotech said in its announcement.

The company is deeply concerned with the critical pandemic circumstances that India is facing at this time, it added.

Serum Institute of India (SII) had on Wednesday slashed the price of its COVID-19 vaccine ‘Covishield’ to Rs 300 per dose from the earlier Rs 400 for state governments. PTI

Advertisement

Suggested Articles

Show comments
Advertisement
Advertisement

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Copyright © The Tribune Trust, 2024
Designed and developed by :  SORTD